EVMN · Evommune, Inc. · Proposed Sales
$6.65
-0.27 (-3.90%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$308.12M
Shares
36.29M
Volume · Oct 5
1.37M
Avg daily vol (3M)
701.83K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-22 | JANICE DREW | Officer | 20,000 | 2026-06-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-02 | DAVID COHEN | Director | 9,258 | 2026-06-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-01 | LUIS PENA | Director, Officer | 24,225 | 2026-06-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-01 | JEEGAR PATEL | Officer | 18,175 | 2026-06-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-28 | GREGORY MOSS | Officer | 14,223 | 2026-05-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-28 | KYLE CARVER | Officer | 25,675 | 2026-05-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–6 of 6 filings